Related Experiment Video
Updated: Jan 31, 2026

Determination of the Relative Potency of an Anti-TNF Monoclonal Antibody mAb by Neutralizing TNF Using an In Vitro Bioanalytical Method
Published on: September 16, 2017
Mycobacterium decipiens Infection in Patient Receiving Anti-TNF-α Therapy, France, 2024.
A rare skin infection caused by Mycobacterium decipiens was successfully treated in an immunocompromised patient. This finding highlights the importance of considering novel mycobacterial species in clinical diagnosis and management.
Area of Science:
- Microbiology
- Infectious Diseases
- Dermatology
Background:
- Mycobacterium decipiens is a recently identified species closely related to Mycobacterium tuberculosis.
- Patients with inflammatory bowel disease (IBD) on anti-tumor necrosis factor-α (anti-TNF-α) therapy may be at increased risk for opportunistic infections.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
09:23Use of the Invertebrate Galleria mellonella as an Infection Model to Study the Mycobacterium tuberculosis Complex
Published on: June 30, 2019
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Receiver Operating Characteristic Plot
Gene Therapy
Group Therapy
α-Alkylation of Ketones via Enolate Ions
Factors Affecting α-Alkylation of Ketones: Choice of Base
The reaction involving bases like EtO− whose conjugate acid EtOH (pKa = 15.9) is stronger than the ketone (pKa = 19.2) results in an equilibrium mixture with higher ketone concentration. As a consequence,...